Public Act 103-0238 Public Act 0238 103RD GENERAL ASSEMBLY |
Public Act 103-0238 | SB1882 Enrolled | LRB103 27260 RLC 53631 b |
|
| AN ACT concerning animals.
| Be it enacted by the People of the State of Illinois,
| represented in the General Assembly:
| Section 1. Short title. This Act may be cited as the | Protection of Dogs and Cats from Unnecessary Testing Act. | Section 5. Definitions. In this Act: | "Alternative test method" means a test method that does | not use animals, or in some cases reduces or refines the use of | animals, for which the reliability and relevance for a | specific purpose has been established by validation bodies, | including, but not limited to, the Inter-Agency Coordinating | Committee for the Validation of Alternative Methods and the | Organisation for Economic Co-operation and Development. | Alternative test methods include, but are not limited to, | high-throughput screening methods, testing of categories of | chemical substances, tiered testing methods, in vitro studies, | and systems biology.
| "Cat" means a small domesticated carnivorous mammal that | is a member of the family Felidae, order Carnivora.
| "Canine or feline toxicological experiment" means any test | or study of any duration that seeks to determine the effect, if | any, of the application or exposure, whether internal or | external, of any amount of a chemical substance on a dog or |
| cat. "Application or exposure" includes, but is not limited | to, oral ingestion, skin or eye contact, or inhalation. | "Application or exposure" does not include testing of | veterinary products for canine or feline health.
| "Chemical substance" means any organic or inorganic | substance, including, but not limited to, a drug, as defined | in Section 321(g) of Title 21 of the United States Code, a | pesticide, as defined in Section 136(u) of Title 7 of the | United States Code, a chemical substance, as defined in | Section 2602(2) of Title 15 of the United States Code, or a | food additive, as defined in Section 321(s) of Title 21 of the | United States Code.
| "Testing facility" means any partnership, corporation, | association, school, institution, organization, or other legal | relationship, whether privately or government owned, leased, | or operated, that tests chemicals, ingredients, product | formulations, or products in this State.
| "Dog" means any member of the species Canis familiaris.
| "Medical research" means research related to the causes, | progression, diagnosis, treatment, control, or prevention of | physical or mental diseases and impairments or chronic | conditions of humans or animals or related to the development | of biomedical products or devices, as defined under Section | 321(h) of Title 21 of the United States Code. Medical research | does not include research related to the development of drugs | as defined in Section 321(g)(1) of Title 21 of the United |
| States Code.
| Section 10. Prohibition on the use of dogs or cats in | toxicological experiments; exemptions; enforcement.
| (a) Notwithstanding any law to the contrary, and in | addition to the prohibitions set forth in law, a testing | facility shall not conduct a canine or feline toxicological | experiment in this State unless the experiment is conducted | for any of the following purposes:
| (1) Medical research.
| (2) To comply with federal requirements pertaining to | the approval or maintenance of a medical device, as | defined under Section 321(h) of Title 21 of the United | States Code.
| (3) To achieve discovery, approval, or maintenance of | a drug, pursuant to a testing requirement imposed by the | United States Food and Drug Administration under Section | 505 or 512 of the Federal Food, Drug, and Cosmetic Act or | Section 351 of the Public Health Service Act or any | binding agency regulation promulgated upon notice and | comment thereunder, if the United States Food and Drug | Administration has not otherwise expressly authorized drug | manufacturers to use alternative test methods.
| (4) To achieve discovery, approval, or maintenance of | a biologic, pursuant to a testing requirement imposed by | the United States Department of Agriculture under the |
| Virus-Serum-Toxin Act or any binding agency regulation | promulgated upon notice and comment thereunder, if the | United States Department of Agriculture has not concluded | that waivers shall be granted for the experimentation or | studies or expressly indicated acceptance of alternative | test methods.
| (5) To achieve discovery, approval, registration, or | maintenance of a pesticide, pursuant to a testing | requirement imposed by the United States Environmental | Protection Agency pursuant to the Federal Insecticide, | Fungicide, and Rodenticide Act, or any binding agency | regulation promulgated upon notice and comment thereunder, | if the Environmental Protection Agency has not concluded | that waivers shall be granted for such experimentation or | studies or expressly indicated acceptance of alternative | test methods.
| (6) To comply with a requirement to conduct the | experiment under the Toxic Substances Control Act, if the | United States Environmental Protection Agency has not, | pursuant to Section 2603(h) of Title 15 of the United | States Code, concluded that waivers shall be granted for | such experimentation or studies or expressly indicated | acceptance of testing methods alternative to laboratory | animal testing, including, but not limited to, in vitro, | in silico, and in chemico approaches for identifying skin | sensitization hazards.
|
| (b)(1) The Attorney General or a State's Attorney in the | county in which a violation of this Act occurred may bring an | action in the name of the People of the State to enforce the | provisions of this Act.
| (2) Whenever the Attorney General, or a State's Attorney | in the county in which a violation of this Act occurred, has | reason to believe that a testing facility has in engaged in or | is engaging in any practice in violation of this Act, and that | proceedings would be in the public interest, he or she may | bring an action in the name of the People of the State against | such testing facility to restrain by preliminary or permanent | injunction the use of that practice.
| (3) If the court determines that the Attorney General or | State's Attorney is the prevailing party in an action filed | pursuant to paragraph (1), the official may recover a civil | penalty not to exceed $5,000 for each day that each dog or each | cat is used in a canine or feline toxicological experiment in | violation of this Section. In addition to the civil penalty, | the official may also recover court costs and attorney's fees.
| (c) The prohibition in subsection (a) does not apply to | testing or experimentation conducted for the purpose of | developing, manufacturing, or marketing any product intended | for beneficial use in dogs or cats.
| Section 97. Severability. The provisions of this Act are | severable under Section 1.31 of the Statute on Statutes. |
| Section 99. Effective date. This Act takes effect upon | becoming law.
|
Effective Date: 6/30/2023
|